<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Alternative medicine interventions for COVID-19</title>
  </titleInfo>
  <name type="personal">
    <namePart>Zia-Ul-Haq, Muhammad</namePart>
    <namePart type="termsOfAddress">Ph.D</namePart>
  </name>
  <name type="personal">
    <namePart>Bin-Jumah, May Nasser.</namePart>
  </name>
  <name type="personal">
    <namePart>Alothman, Sarah I.</namePart>
  </name>
  <name type="personal">
    <namePart>Henidi, Hanan A.</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="">Electronic books.</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">sz</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Cham</placeTerm>
    </place>
    <publisher>Springer</publisher>
    <dateIssued>2021</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="gmd">electronic resource</form>
    <extent>1 online resource (291 p.)</extent>
  </physicalDescription>
  <abstract>This research volume examines the available alternative, complementary, pharmaceutical and vaccine methods for treating, mitigating, or preventing COVID-19. Coverage includes traditional Chinese medicine, herbal remedies, nutraceutical/dietary options, and drug/vaccine therapies. All the methods discussed will be critically examined to provide readers with a full, unbiased overview that includes pros/cons of each method. While the nature of COVID-19 is still being studied, and new research and theories are being published daily, this book endeavors to provide readers with a comprehensive summary of current research on alternative and mainstream treatment and prevention methods.</abstract>
  <tableOfContents>Intro -- Preface -- Contents -- About the Editors -- Chapter 1: Introduction to COVID-19 -- Introduction -- Origin of COVID -- Emergence and Epidemiology -- Human-Animal Interaction as Risk Factor -- Best Suitable Animal Model -- COVID and Animal Welfare -- Molecular Differences Between Different Animal Species -- Vaccines for COVID from Animals -- Conclusion -- References -- Chapter 2: Medicinal Plants as COVID-19 Remedy -- Introduction -- Existing Plants with Potential Therapeutic Applications for Coronavirus Family (SARS-CoV) -- Plants as Specific Inhibitors of HCoV Target Proteins</tableOfContents>
  <tableOfContents>Bupleurum Species -- Artemisia annua L. -- Isatis indigotica Fortune ex Lindl. -- Alcea digitata (Boiss.) Alef. -- Lycoris radiata (L'H�er.) Herb. -- Pyrrosia lingua (Thunb.) Farw. -- Houttuynia cordata Thunb. -- Torreya nucifera L. -- Lindera aggregata (Sims) Kosterm. -- Rheum palmatum L. -- Cerasus avium (L.) Moench. -- Polygonum multiflorum Thunb. -- Citrus aurantium L. -- Rubia tinctorum L. -- Onopordum acanthium L. -- Quercus infectoria G. Olivier -- Crataegus microphylla C. Koch -- Berberis integerrima Bunge -- Alnus japonica (Thunb.) Steud. -- Paulownia tomentosa (Thunb.) Steud.</tableOfContents>
  <tableOfContents>Psoralea corylifolia L. -- Tribulus terrestris L. -- Medicinal Plants as Potential Source of Natural Antiviral Agents Against COVID -19 -- Allium Sativum (Garlic) -- Azadirachta indica (Neem) -- Curcuma domestica (Turmeric, Haldi) -- Echinacea purpurea L. (Echinacea) -- Foeniculum vulgare Mill. (Fennel) -- Glycyrrhiza glabra (Licorice) -- Melissa officinalis L. (Lemon Balm) -- Mentha piperita L. (Peppermint) -- Nigella sativa L. (Black Seeds) -- Origanum vulgare L. (Oregano) -- Ocimum bacilicum L. (Basil) -- Rosmarinus officinalis L. (Rosemary) -- Salvia officinalis L. (Sage)</tableOfContents>
  <tableOfContents>Senna alexandrina Mill. (Senna Makki) -- Zingiber officinale Rosc. (Ginger) -- Limitations -- Conclusions -- References -- Chapter 3: Traditional Chinese Medicines as Possible Remedy Against SARS-CoV-2 -- Introduction -- Traditional Chinese Medical Practices -- Laws for TCM Formulation -- Antiviral Potential of Plant Metabolites -- Structure of SARS-CoV-2 -- Relevance of SARS-CoV with SARS-CoV-2 -- Entry of SARS-CoV vs. SARS-CoV-2 into Host Cell -- TCM and SARS-CoV -- TCM and SARS-CoV-2 (COVID-19) -- Most Practiced Herbs in Formulations Against COVID-19</tableOfContents>
  <tableOfContents>Utilization Frequency of Herbs in the Formulation of (COVID-19) Decoctions -- Approved/Proposed Decoctions with Successful Clinical Trials -- Qingfei Paidu Decoction (QFPD) (Approved) -- Huashi Baidu Decoction (HBD) (Approved) -- Xiaochaihu Decoction (XCHD) -- Xuanfei Baidu Decoction (XFBD) (Approved) -- Jinhua Qinggan (JQ) (Approved) -- Huoxiang Zhengqi (HZ) Capsule -- Lianhua Qingwen (LQ) -- Xuebijing Injection (XbI) (Approved) -- Reduning Injection (RdI) -- Shufeng Jiedu Capsule (SFJC) -- Ma Xing Shi Gan Decoction (MXSGD) (Approved) -- Yin Qiao San (YQS) -- Yupingfeng San (YPFS)</tableOfContents>
  <note type="statement of responsibility">Muhammad Zia-Ul-Haq, May Nasser Bin-Jumah, Sarah I. Alothman,  Hanan A. Henidi, editors.</note>
  <note>Therapeutic Logic of TCM as COVID-19 Inhibitor.</note>
  <note>References -- Chapter 5: Foods as First Defense Against COVID-19 -- Introduction -- Role of Nutrition and Diet in Prevention and Management of COVID-19 -- Prioritizing Nutrition Interventions During COVID-19 -- Grains -- Vegetables and Fruits -- Nuts -- Legumes -- Meat -- Milk and Milk Products -- Herbs -- Role of Vitamins in COVID-19 -- Vitamin A -- Vitamin B -- Vitamin C -- Vitamin D -- Vitamin E -- Role of Minerals in COVID-19 -- Iron -- Selenium -- Zinc -- Magnesium -- Role of Omega-3 Polyunsaturated Fatty Acids -- Nutrients for Immune System and Resilience in COVID-19 -- Nutrition in Lowering Stress and Depression in COVID-19 -- Food Choices for Diabetic Patients During COVID-19 -- Food Choices for Cardiovascular Patients During COVID-19 -- Food Choices for Cancer Patients During COVID-19 -- Food Choices for Patients with Digestive Disorders During COVID-19 -- Food Choices for Pulmonary Disease Patients During COVID-19 -- Malnutrition May Exacerbate COVID-19 -- Nutrition and Post-COVID Recovery -- Future Perspectives -- Conclusion -- References -- Chapter 6: Drugs for the Treatment of COVID-19 -- Introduction -- Dexamethasone -- Chloroquine -- Remdesivir -- Angiotensin-Converting Enzyme Inhibitors -- Spike Protein Inhibitors -- Conclusions -- References -- Chapter 7: COVID-19 Pandemic and Vaccines -- Introduction -- COVID-19 Vaccines: A Need of Time -- Coronavirus Vaccine Development: Challenges of the Past -- Vaccine Development Strategies -- Nucleic Acid Vaccines -- Protein Subunit Vaccines -- Inactivated or Live-Attenuated Virus Vaccines -- Virus Vector-Based Vaccines -- Repurposed Vaccines for COVID-19 and Off-Target Effects of Other Vaccines -- Plant-Based Vaccines -- Animal Models for SARS-CoV-2 Studies -- Cell Culture Systems for SARS-CoV-2 Studies -- Clinical and Immunological Endpoints -- Vaccine Development Landscape.</note>
  <subject authority="lcsh">
    <topic>COVID-19 (Disease)</topic>
    <topic>Alternative treatment</topic>
  </subject>
  <subject authority="fast">
    <topic>Alternative medicine</topic>
  </subject>
  <subject authority="fast">
    <topic>Behavior therapy</topic>
  </subject>
  <subject authority="fast">
    <topic>Food</topic>
    <topic>Biotechnology</topic>
  </subject>
  <subject authority="fast">
    <topic>Immunology</topic>
  </subject>
  <subject authority="fast">
    <topic>Nutrition</topic>
  </subject>
  <subject authority="fast">
    <topic>Virology</topic>
  </subject>
  <classification authority="lcc">RC772.V5</classification>
  <classification authority="ddc" edition="23">616.2/41406</classification>
  <relatedItem type="otherFormat" displayLabel="Print version:">
    <titleInfo>
      <title>Alternative Medicine Interventions for COVID-19</title>
    </titleInfo>
    <name>
      <namePart>Zia-Ul-Haq, Muhammad</namePart>
    </name>
    <originInfo>
      <publisher>Cham : Springer International Publishing AG,c2021</publisher>
    </originInfo>
  </relatedItem>
  <identifier type="isbn">9783030679897</identifier>
  <identifier type="isbn">3030679896</identifier>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="isbn">9783030679903</identifier>
  <identifier type="isbn">303067990X</identifier>
  <identifier type="isbn">9783030679910</identifier>
  <identifier type="isbn">3030679918</identifier>
  <identifier type="uri">https://search.ebscohost.com/login.aspx?direct=true&amp;scope=site&amp;db=nlebk&amp;db=nlabk&amp;AN=2901702</identifier>
  <location>
    <url displayLabel="EBSCOhost">https://search.ebscohost.com/login.aspx?direct=true&amp;scope=site&amp;db=nlebk&amp;db=nlabk&amp;AN=2901702</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">EBLCP</recordContentSource>
    <recordCreationDate encoding="marc">210403</recordCreationDate>
    <recordChangeDate encoding="iso8601">20220526094103.0</recordChangeDate>
    <recordIdentifier source="OCoLC">on1244623089</recordIdentifier>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
